Status:
COMPLETED
Fertility and Pregnancy in Patients With Classic Congenital Adrenal Hyperplasia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Classic Congenital Adrenal Hyperplasia
Eligibility:
All Genders
18-80 years
Brief Summary
Classic congenital adrenal hyperplasia (CAH) is a rare genetic endocrine disorder. Its prevalence is around 1/15.000. It results from a deficiency in 21-hydroxylase, an adrenal steroidogenic enzyme in...
Eligibility Criteria
Inclusion
- for patient :
- Adult patient \> 18 years
- Classical congenital adrenal hyperplasia (21-hydroxylase deficiency, 11β-hydroxylase deficiency and 3βHSD2 deficiency)
- Who have indicated that they do not object to participating in the sudy
- For partners :
- \- No objection to the collection of their fertility data
Exclusion
- Non classical congenital adrenal hyperplasia
- Classical congenital adrenal hyperplasia due to other enzyme block
Key Trial Info
Start Date :
January 16 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 16 2024
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06153043
Start Date
January 16 2024
End Date
February 16 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endocrinology Department of Louis Pradel Hospital
Bron, France, 69677